The Latest in Cleveland Clinic Journal of Medicine

Understanding the pathogenesis of ANCA: Where are we today?

April 1, 2002

ANCA subsets: Influence on disease phenotype

April 1, 2002

Genetics of ANCA-associated vasculitides

April 1, 2002

Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: The pathogenic and diagnostic implications

April 1, 2002

Kawasaki disease: Etiology, pathogenesis, and treatment

April 1, 2002

Epidemiology of giant-cell arteritis

April 1, 2002

Epidemiology of Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome

April 1, 2002

Epidemiology of Henoch-Schönlein purpura

April 1, 2002

Cytokines in giant-cell arteritis

April 1, 2002

Utility of imaging studies in assessment of vascular inflammation

April 1, 2002

Measuring disease activity and outcomes in clinical studies

April 1, 2002

Diagnostic strategies in vasculitis affecting the central nervous system

April 1, 2002

Conventional treatment and outcome of Wegener's granulomatosis and microscopic polyangiitis

April 1, 2002

Treatment of giant-cell arteritis: Where we have been and why we must move on

April 1, 2002

Henoch-Schönlein purpura (treatment and outcome)

April 1, 2002